Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CB-AC-02
- Development stage
- Phase 2
- Lead developer
- CHA Biotech
- Modality
- Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
CB-AC-02 is a human placenta-derived mesenchymal stem cell therapy developed for the treatment of Alzheimer's disease. It is designed as a cell replacement therapy, aiming to restore or replace damaged or lost cells in the nervous system. The product consists of mesenchymal stem cells sourced from human placental tissue and is administered via injection, specifically intravenous infusion. The primary mechanism of action involves cellular replacement and regenerative effects within neural tissues, potentially addressing neurodegeneration associated with Alzheimer's disease. CB-AC-02 has been evaluated in phase 1/2 clinical trials for safety and potential therapeutic effect in patients with probable Alzheimer's disease[1][2][3][4].
- Other names
- Placenta-derived mesenchymal stem cell therapies
Beyond the preview
Go deeper on CB-AC-02.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CB-AC-02.